https://www.selleckchem.com/pr....oducts/nvp-bgt226.ht
In clinical practice, the amy-PET is globally inspected to provide a binary outcome, but the role of a regional assessment has not been fully investigated yet. To deepen the role of regional amyloid burden and its implication on clinical-neuropsychological features. Amy-PET and a complete neuropsychological assessment (Trail Making Test, Rey Auditory Verbal Learning Test, semantic verbal fluency, Symbol Digit, Stroop, visuoconstruction) were available in 109 patients with clinical suspicion of Alzheimer's disease. By averaging the st
Like
Comment
Share
